A detailed history of Sg Americas Securities, LLC transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 11,606 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,606
Holding current value
$0
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
N/A
11,606 New
11,606 $119,000
Q1 2022

Apr 29, 2022

SELL
$3.51 - $6.74 $40,031 - $76,869
-11,405 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$6.03 - $11.67 $12,379 - $23,958
-2,053 Reduced 15.25%
11,405 $76,000
Q3 2021

Nov 01, 2021

BUY
$9.98 - $35.22 $69,031 - $243,616
6,917 Added 105.75%
13,458 $134,000
Q2 2021

Aug 12, 2021

BUY
$24.71 - $44.28 $161,628 - $289,635
6,541 New
6,541 $202,000
Q1 2021

May 13, 2021

SELL
$37.62 - $60.41 $485,297 - $779,289
-12,900 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$25.0 - $46.34 $322,500 - $597,786
12,900 New
12,900 $598,000

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.